Atisnolerbart(TD-PR095026) is a research-grade recombinant antibody targetingMajor pollen allergen Bet v 1-A. Produced in mammalian cells with native-like glycosylation.HighlightsResearch Grade— For PK/PD studies, assay development, and ADA research.Native Glycosylation— Mammalian expression ensures native-like patterns.
Species reactivity
Betula pendula (European white birch) (Betula verrucosa)
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host species
Human
Isotype
IgG4-kappa
Clonality
Monoclonal
Target
Major pollen allergen Bet v 1-A, Allergen Bet v I-A, Bet v 1-A, BETVIA, BETVI
Endotoxin level
Please contact the lab for this information.
Purity
>95% purity as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P15494
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names
2456308-79-3
Background
Atisnolerbart is a human IgG4 antibody targeting BETVIA, the major birch pollen allergen Betv 1-A.
Caption
SDS-PAGE for Research Grade Atisnolerbart. | Detects recombinant Bet v 1 (Catalog No:TD-PR095012) in indirect ELISA.
Note
For research use only. Not suitable for clinical or therapeutic use.